As of 2025-07-12, the Relative Valuation of Charles River Laboratories International Inc (CRL) is 35.40 USD. This relative valuation is based on P/E multiples. With the latest stock price at 159.40 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is -77.8%.
The range of the Relative Valuation is (13.15) - 120.13 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 27.1x | 21.7x |
| Forward P/E multiples | 19.6x - 33.0x | 23.2x |
| Fair Price | (13.15) - 120.13 | 35.40 |
| Upside | -108.2% - -24.6% | -77.8% |
| Date | P/E |
| 2025-07-10 | -254.70 |
| 2025-07-09 | -247.40 |
| 2025-07-08 | -246.49 |
| 2025-07-07 | -239.51 |
| 2025-07-03 | -244.52 |
| 2025-07-02 | -245.09 |
| 2025-07-01 | -240.29 |
| 2025-06-30 | -236.13 |
| 2025-06-27 | -233.45 |
| 2025-06-26 | -235.91 |
| 2025-06-25 | -233.76 |
| 2025-06-24 | -230.95 |
| 2025-06-23 | -229.36 |
| 2025-06-20 | -229.47 |
| 2025-06-18 | -226.11 |
| 2025-06-17 | -225.73 |
| 2025-06-16 | -235.04 |
| 2025-06-13 | -232.58 |
| 2025-06-12 | -236.38 |
| 2025-06-11 | -235.17 |
| 2025-06-10 | -234.99 |
| 2025-06-09 | -229.49 |
| 2025-06-06 | -225.19 |
| 2025-06-05 | -219.74 |
| 2025-06-04 | -222.89 |
| 2025-06-03 | -215.53 |
| 2025-06-02 | -210.16 |
| 2025-05-30 | -211.07 |
| 2025-05-29 | -214.30 |
| 2025-05-28 | -212.04 |
| 2025-05-27 | -215.77 |
| 2025-05-23 | -212.79 |
| 2025-05-22 | -211.03 |
| 2025-05-21 | -210.06 |
| 2025-05-20 | -223.37 |
| 2025-05-19 | -220.02 |
| 2025-05-16 | -219.38 |
| 2025-05-15 | -216.15 |
| 2025-05-14 | -216.24 |
| 2025-05-13 | -224.13 |
| 2025-05-12 | -222.67 |
| 2025-05-09 | -215.99 |
| 2025-05-08 | -219.99 |
| 2025-05-07 | -213.16 |
| 2025-05-06 | -179.61 |
| 2025-05-05 | -185.88 |
| 2025-05-02 | -184.35 |
| 2025-05-01 | -181.91 |
| 2025-04-30 | -184.60 |
| 2025-04-29 | -182.53 |